Bedford, MA, United States of America

Christopher Borella

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Cambridge, MA (US) (2010 - 2013)
  • Bedford, MA (US) (2009 - 2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Christopher Borella: Innovator in Proliferative Disorder Treatments

Introduction

Christopher Borella is a notable inventor based in Bedford, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Borella has made strides in developing innovative compounds aimed at treating proliferative disorders. His work reflects a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest patents, Borella has focused on compounds for the treatment of proliferative disorders. These inventions relate to compounds of structural formula (I), showcasing his dedication to addressing complex medical challenges through innovative solutions.

Career Highlights

Borella is currently associated with Synta Pharmaceuticals Corporation, where he applies his expertise in pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work.

Collaborations

Throughout his career, Borella has worked alongside esteemed colleagues such as Shoujun Chen and Lijun Sun. These collaborations have contributed to the advancement of research and the successful development of new therapeutic compounds.

Conclusion

Christopher Borella's innovative work in the treatment of proliferative disorders exemplifies the vital role of inventors in the pharmaceutical industry. His contributions continue to pave the way for new medical advancements that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…